Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

April 30-30, 2021

2nd International Conference on Nucleic Acids

London, UK
May 17-18, 2021

11th World Glycobiology Congress

Vienna, Austria
July 26-27, 2021

5th International Conference on Bioscience and Biotechnology

London, Aland Islands
March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
July 30-30, 2021

Glycobiology Biochem Conference 2021

London, UK
August 17-18, 2021

23rd Global Biotechnology Congress

Rome, Italy
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland
December 01-02, 2021

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 03-04, 2021

International Conference on Biotechnology

Singapore, Singapore

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in